Influence Graph Timelines Actor desks
2653 monitored
← Actor desksRead-only · existing recordsClassic graph view ↗

Sentinels / Actor desk

Co Founder Principal Consultant

organization · Registry status: unverified

5de4e19d-c7d4-5d61-b862-aaba07ca080d

Evidence, not intent.

Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.

No claim of complete coverage or live monitoring.

Observation window

UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.

Recent observations / timeline

The source record

1 distinct events shown, newest first. Headlines may be generated summaries; inspect the source before repeating a claim.

  1. Alkermes plc: Alkermes to Present New Data on Alixorexton and LUMRYZ (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research

    Recorded role: co mention · USPEC_POLICY1

    Open source ↗

Signals to inspect

Anomalies

Latest 0 in the selected window (up to 10). Detector output, not verified conclusions.

No stored anomalies in this window.

Narrative context

Unresolved threads

Latest 20 at most, across all dates. Stored narratives require human review.

No unresolved threads recorded.

Stored connections

Relationships

Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.

Ask this desk

Desk analyst

Read-only questions about Co Founder Principal Consultant's stored record. Answers cite only records retrieved for that turn; a citation chip opens the existing inspection view. Absence of matches is not evidence of inactivity.

Operator sign-in is required. Sign in

Identity is the existing actor registry record. Entity resolution and source coverage may be incomplete.